Drug Related Problems, Pharmaceutical Care
Conditions
Keywords
secondary prevention, pharmaceutical care, drug related problems, emergency department
Brief summary
Background: Although Drug- related Problems (DRPs) in polimedicated patients are a major public health problem in western countries and many of them have been considered avoidable, secondary and primary prevention policies have not been systematized, beyond pharmaceutical care programs in certain settings and on specific patients. Objectives: The main objective of this study is to evaluate the impact of implementing the Medication Code (CM) on patients who consult the emergency department for a DRP (secondary prevention of DRP). It is also intended to draw conclusions, based on the knowledge obtained in terms of DRP that will allow the establishment of future actions to reduce its prevalence (primary prevention actions). Method: A single-centre clinical trial is proposed in which adult patients will be selected to consult the Hospital Emergency Department (ED) of the Hospital de la Santa Creu i Sant Pau (HSCSP) for a primary or secondary diagnosis of DRP and will be randomised with a 1:1 distribution to be included in the medication code (intervention group) or to receive usual care (control group). The intervention will be evaluated in terms of health outcomes (ED consultations and hospital readmission).
Detailed description
A single-centre clinical trial is proposed in which adult patients will be selected to consult the Hospital Emergency Department (ED) of the Hospital de la Santa Creu i Sant Pau (HSCSP) for a primary or secondary diagnosis of DRP and will be randomised with a 1:1 distribution to be included in the medication code (intervention group) or to receive usual care (control group). The intervention will be evaluated in terms of health outcomes (ED consultations and hospital readmission).
Interventions
PROCEDURESecondary prevention program for drug related problems
The interventions consists of three stages: 1) actions aimed at improving the chronic prescription of the patient, 2) actions aimed at improving the therapeutic adherence and 3) actions aimed at improving the assistance healthcare levels coordination
Sponsors
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Age \>= 18 years * Drug Related Problems (DRP) related to drugs from Anatomical Therapeutic Chemical (ATC) groups A, B and C
Exclusion criteria
* DRP due to autolytic attempt or final phase of life. * Denied informed consent
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| 30 day readmission | 30 days | Readmissions during the 30 days after the intervention in any hospital centre from the Àrea Integral de Salut Barcelona Dreta after consulting the Hospital de la Santa Creu i Sant Pau (HSCSP) emergency department. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| 30 day consultation | 30 days | Consultation 30 days after the intervention for any cause to the HSCSP |
| 30 day mortality | 30 days | Any cause mortality 30 days after the intervention |
| Time on Emergency Department | 72 hours | Time from patient admission to discharge from the emergency department |
Countries
Spain
Contacts
Primary ContactAna M Juanes, PhD
Backup ContactJesus Ruiz, PhD
Outcome results
None listed